mRNA Vaccine Market Report

Global mRNA Vaccine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：May 07, 2021
  • PAGES：194
  • REPORT CODE：GMM659605
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The mRNA Vaccine is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global mRNA Vaccine market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the mRNA Vaccine industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global mRNA Vaccine Market Segmentations:

    By Players:

    • Ethris

    • Translate Bio

    • Moderna Therapeutics

    • Sangamo Therapeutics

    • eTheRNA

    • Argos Therapeutics

    • In-Cell-Art

    • BioNTech

    • CureVac

    • Tiba Biotechnology

    By Types:

    • Standardization Of Cancer Treatment MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    By End-User:

    • Infectious Disease

    • Cancer

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of mRNA Vaccine Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global mRNA Vaccine Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2014 to 2026

      • 1.3.2 Global mRNA Vaccine Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2014 to 2026

      • 1.3.3 Global mRNA Vaccine Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2014 to 2026

      • 1.3.4 Global mRNA Vaccine Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global mRNA Vaccine Market Size and Growth Rate of Infectious Disease from 2014 to 2026

      • 1.4.2 Global mRNA Vaccine Market Size and Growth Rate of Cancer from 2014 to 2026

      • 1.4.3 Global mRNA Vaccine Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina mRNA Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of mRNA Vaccine Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of mRNA Vaccine by Major Types

      • 3.4.1 mRNA Vaccine Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

      • 3.4.2 mRNA Vaccine Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

      • 3.4.3 mRNA Vaccine Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine

      • 3.4.4 mRNA Vaccine Market Size and Growth Rate of Infection Prevention MRNA Vaccine

    4 Segmentation of mRNA Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of mRNA Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of mRNA Vaccine in Infectious Disease

      • 4.4.2 Market Size and Growth Rate of mRNA Vaccine in Cancer

      • 4.4.3 Market Size and Growth Rate of mRNA Vaccine in Other

    5 Market Analysis by Major Regions

    • 5.1 Global mRNA Vaccine Production Analysis by Major Regions

    • 5.2 Global mRNA Vaccine Consumption Analysis by Major Regions

    • 5.3 Global mRNA Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America mRNA Vaccine Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe mRNA Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific mRNA Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa mRNA Vaccine Production, Import, Consumption and Export Analysis

    6 Product Commodity of mRNA Vaccine Market in Major Countries

    • 6.1 Top 5 Export Countries in mRNA Vaccine market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in mRNA Vaccine market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in mRNA Vaccine market from 2014 to 2019

    • 6.2 Top 5 Import Countries in mRNA Vaccine market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in mRNA Vaccine market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in mRNA Vaccine market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America mRNA Vaccine Landscape Analysis

    • 7.1 North America mRNA Vaccine Landscape Analysis by Major Types

    • 7.2 North America mRNA Vaccine Landscape Analysis by Major End-Users

    • 7.3 North America mRNA Vaccine Landscape Analysis by Major Countries

      • 7.3.1 United States mRNA Vaccine Market Volume and Growth Rate

      • 7.3.2 Canada mRNA Vaccine Market Volume and Growth Rate

      • 7.3.3 Mexico mRNA Vaccine Market Volume and Growth Rate

    8 Europe mRNA Vaccine Landscape Analysis

    • 8.1 Europe mRNA Vaccine Landscape Analysis by Major Types

    • 8.2 Europe mRNA Vaccine Landscape Analysis by Major End-Users

    • 8.3 Europe mRNA Vaccine Landscape Analysis by Major Countries

      • 8.3.1 Germany mRNA Vaccine Market Volume and Growth Rate

      • 8.3.2 UK mRNA Vaccine Market Volume and Growth Rate

      • 8.3.3 France mRNA Vaccine Market Volume and Growth Rate

      • 8.3.4 Italy mRNA Vaccine Market Volume and Growth Rate

      • 8.3.5 Nordic Countries mRNA Vaccine Market Volume and Growth Rate

      • 8.3.6 Spain mRNA Vaccine Market Volume and Growth Rate

      • 8.3.7 Belgium mRNA Vaccine Market Volume and Growth Rate

      • 8.3.8 Poland mRNA Vaccine Market Volume and Growth Rate

      • 8.3.9 Russia mRNA Vaccine Market Volume and Growth Rate

      • 8.3.10 Turkey mRNA Vaccine Market Volume and Growth Rate

    9 Asia Pacific mRNA Vaccine Landscape Analysis

    • 9.1 Asia Pacific mRNA Vaccine Landscape Analysis by Major Types

    • 9.2 Asia Pacific mRNA Vaccine Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific mRNA Vaccine Landscape Analysis by Major Countries

      • 9.3.1 China mRNA Vaccine Market Volume and Growth Rate

      • 9.3.2 Japan mRNA Vaccine Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand mRNA Vaccine Market Volume and Growth Rate

      • 9.3.4 India mRNA Vaccine Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries mRNA Vaccine Market Volume and Growth Rate

      • 9.3.6 South Korea mRNA Vaccine Market Volume and Growth Rate

    10 Latin America, Middle East & Africa mRNA Vaccine Landscape Analysis

    • 10.1 Latin America, Middle East & Africa mRNA Vaccine Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa mRNA Vaccine Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa mRNA Vaccine Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries mRNA Vaccine Market Volume and Growth Rate

      • 10.3.2 Brazil mRNA Vaccine Market Volume and Growth Rate

      • 10.3.3 Nigeria mRNA Vaccine Market Volume and Growth Rate

      • 10.3.4 South Africa mRNA Vaccine Market Volume and Growth Rate 

      • 10.3.5 Argentina mRNA Vaccine Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Ethris

      • 11.1.1 Ethris Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Translate Bio

      • 11.2.1 Translate Bio Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Moderna Therapeutics

      • 11.3.1 Moderna Therapeutics Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Sangamo Therapeutics

      • 11.4.1 Sangamo Therapeutics Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 eTheRNA

      • 11.5.1 eTheRNA Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Argos Therapeutics

      • 11.6.1 Argos Therapeutics Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 In-Cell-Art

      • 11.7.1 In-Cell-Art Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 BioNTech

      • 11.8.1 BioNTech Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 CureVac

      • 11.9.1 CureVac Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Tiba Biotechnology

      • 11.10.1 Tiba Biotechnology Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 120 Figures and 136 Tables)

    • Figure Product Picture

    • Figure mRNA Vaccine Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2014 to 2026

    • Figure mRNA Vaccine Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2014 to 2026

    • Figure mRNA Vaccine Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2014 to 2026

    • Figure mRNA Vaccine Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Infectious Disease from 2014 to 2026

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina mRNA Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of mRNA Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of mRNA Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of mRNA Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of mRNA Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Infection Prevention MRNA Vaccine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of mRNA Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of mRNA Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Infectious Disease

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Other

    • Table Global mRNA Vaccine Production by Major Regions

    • Table Global mRNA Vaccine Production Share by Major Regions

    • Figure Global mRNA Vaccine Production Share by Major Regions in 2014

    • Figure Global mRNA Vaccine Production Share by Major Regions in 2018

    • Figure Global mRNA Vaccine Production Share by Major Regions in 2026

    • Table Global mRNA Vaccine Consumption by Major Regions

    • Table Global mRNA Vaccine Consumption Share by Major Regions

    • Figure Global mRNA Vaccine Consumption Share by Major Regions in 2014

    • Figure Global mRNA Vaccine Consumption Share by Major Regions in 2018

    • Figure Global mRNA Vaccine Consumption Share by Major Regions in 2026

    • Table North America mRNA Vaccine Production, Import, Consumption and Export Analysis

    • Table Europe mRNA Vaccine Production, Import, Consumption and Export Analysis

    • Table Asia Pacific mRNA Vaccine Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa mRNA Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in mRNA Vaccine market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in mRNA Vaccine market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in mRNA Vaccine market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in mRNA Vaccine market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America mRNA Vaccine Consumption by Types from 2014 to 2026

    • Table North America mRNA Vaccine Consumption Share by Types from 2014 to 2026

    • Figure North America mRNA Vaccine Consumption Share by Types in 2014

    • Figure North America mRNA Vaccine Consumption Share by Types in 2018

    • Figure North America mRNA Vaccine Consumption Share by Types in 2026

    • Table North America mRNA Vaccine Consumption by End-Users from 2014 to 2026

    • Table North America mRNA Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure North America mRNA Vaccine Consumption Share by End-Users in 2014

    • Figure North America mRNA Vaccine Consumption Share by End-Users in 2018

    • Figure North America mRNA Vaccine Consumption Share by End-Users in 2026

    • Table North America mRNA Vaccine Consumption by Major Countries from 2014 to 2026

    • Table North America mRNA Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure North America mRNA Vaccine Consumption Share by Major Countries in 2014

    • Figure North America mRNA Vaccine Consumption Share by Major Countries in 2018

    • Figure North America mRNA Vaccine Consumption Share by Major Countries in 2026

    • Figure United States mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Europe mRNA Vaccine Consumption by Types from 2014 to 2026

    • Table Europe mRNA Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Europe mRNA Vaccine Consumption Share by Types in 2014

    • Figure Europe mRNA Vaccine Consumption Share by Types in 2018

    • Figure Europe mRNA Vaccine Consumption Share by Types in 2026

    • Table Europe mRNA Vaccine Consumption by End-Users from 2014 to 2026

    • Table Europe mRNA Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Europe mRNA Vaccine Consumption Share by End-Users in 2014

    • Figure Europe mRNA Vaccine Consumption Share by End-Users in 2018

    • Figure Europe mRNA Vaccine Consumption Share by End-Users in 2026

    • Table Europe mRNA Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Europe mRNA Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe mRNA Vaccine Consumption Share by Major Countries in 2014

    • Figure Europe mRNA Vaccine Consumption Share by Major Countries in 2018

    • Figure Europe mRNA Vaccine Consumption Share by Major Countries in 2026

    • Figure Germany mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure UK mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure France mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific mRNA Vaccine Consumption by Types from 2014 to 2026

    • Table Asia Pacific mRNA Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific mRNA Vaccine Consumption Share by Types in 2014

    • Figure Asia Pacific mRNA Vaccine Consumption Share by Types in 2018

    • Figure Asia Pacific mRNA Vaccine Consumption Share by Types in 2026

    • Table Asia Pacific mRNA Vaccine Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific mRNA Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific mRNA Vaccine Consumption Share by End-Users in 2014

    • Figure Asia Pacific mRNA Vaccine Consumption Share by End-Users in 2018

    • Figure Asia Pacific mRNA Vaccine Consumption Share by End-Users in 2026

    • Table Asia Pacific mRNA Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific mRNA Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific mRNA Vaccine Consumption Share by Major Countries in 2014

    • Figure Asia Pacific mRNA Vaccine Consumption Share by Major Countries in 2018

    • Figure Asia Pacific mRNA Vaccine Consumption Share by Major Countries in 2026

    • Figure China mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandmRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure India mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccine Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa mRNA Vaccine Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa mRNA Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa mRNA Vaccine Consumption Share by Major Countries in 2026

    • Figure GCC Countries mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina mRNA Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Ethris

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ethris

    • Figure Sales and Growth Rate Analysis of Ethris

    • Figure Revenue and Market Share Analysis of Ethris

    • Table Product and Service Introduction of Ethris

    • Table Company Profile and Development Status of Translate Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Translate Bio

    • Figure Sales and Growth Rate Analysis of Translate Bio

    • Figure Revenue and Market Share Analysis of Translate Bio

    • Table Product and Service Introduction of Translate Bio

    • Table Company Profile and Development Status of Moderna Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics

    • Figure Sales and Growth Rate Analysis of Moderna Therapeutics

    • Figure Revenue and Market Share Analysis of Moderna Therapeutics

    • Table Product and Service Introduction of Moderna Therapeutics

    • Table Company Profile and Development Status of Sangamo Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo Therapeutics

    • Figure Sales and Growth Rate Analysis of Sangamo Therapeutics

    • Figure Revenue and Market Share Analysis of Sangamo Therapeutics

    • Table Product and Service Introduction of Sangamo Therapeutics

    • Table Company Profile and Development Status of eTheRNA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of eTheRNA

    • Figure Sales and Growth Rate Analysis of eTheRNA

    • Figure Revenue and Market Share Analysis of eTheRNA

    • Table Product and Service Introduction of eTheRNA

    • Table Company Profile and Development Status of Argos Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Argos Therapeutics

    • Figure Sales and Growth Rate Analysis of Argos Therapeutics

    • Figure Revenue and Market Share Analysis of Argos Therapeutics

    • Table Product and Service Introduction of Argos Therapeutics

    • Table Company Profile and Development Status of In-Cell-Art

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of In-Cell-Art

    • Figure Sales and Growth Rate Analysis of In-Cell-Art

    • Figure Revenue and Market Share Analysis of In-Cell-Art

    • Table Product and Service Introduction of In-Cell-Art

    • Table Company Profile and Development Status of BioNTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech

    • Figure Sales and Growth Rate Analysis of BioNTech

    • Figure Revenue and Market Share Analysis of BioNTech

    • Table Product and Service Introduction of BioNTech

    • Table Company Profile and Development Status of CureVac

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac

    • Figure Sales and Growth Rate Analysis of CureVac

    • Figure Revenue and Market Share Analysis of CureVac

    • Table Product and Service Introduction of CureVac

    • Table Company Profile and Development Status of Tiba Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiba Biotechnology

    • Figure Sales and Growth Rate Analysis of Tiba Biotechnology

    • Figure Revenue and Market Share Analysis of Tiba Biotechnology

    • Table Product and Service Introduction of Tiba Biotechnology


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US